An experimental study in a mouse model of imiquimod-induced psoriasis concluded that treatment with an inflammasome blocker caused reduced expression of pNF-kB, pSTAT-3, IL-6, and TNFα [18]. This evidence concerns the gene IL6 and psoriasis.